AIM ImmunoTech (AIM) Preferred Shares (2019 - 2024)
AIM ImmunoTech's Preferred Shares was $689,000 in Q1 2024, down 0.4% from $692,000 a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
AIM ImmunoTech (AIM) Preferred Shares (2019 - 2024) Analysis & Trends
From Q1 2019 onward, AIM ImmunoTech has reported Preferred Shares for 21 quarters.
- Preferred Shares has now declined for four consecutive years, with a four-year compound annual growth rate of -3.0% (FY2019 to FY2023).
- In earlier years, Preferred Shares was $696,000 in FY2022 (-2.7%), $715,000 in FY2021 (-2.3%), $732,000 in FY2020 (-5.9%) and $778,000 in FY2019.
- Quarterly Preferred Shares has moved between $689,000 (Q4 2023) and $1.22 million (Q2 2019) over five years.
- Compared with a year earlier, Preferred Shares has declined for 17 straight quarters, with an average decline of 2.1% over the last eight quarters.
- Across the past five years, year-over-year decline in Preferred Shares ran from 0.4% in Q1 2024 to 69.5% in Q1 2020.
- Per Business Quant data, AIM's Preferred Shares in the three quarters before Q1 2024 was $689,000 (Q4 2023), $690,000 (Q3 2023) and $690,000 (Q2 2023).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | - |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | - |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | - |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | - |
| 10 | AIM ImmunoTech | 3.08 Mn | -18.22 Mn | 21,000.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2024 | 689,000.00 |
| Dec 31, 2023 | 689,000.00 |
| Sep 30, 2023 | 690,000.00 |
| Jun 30, 2023 | 690,000.00 |
| Mar 31, 2023 | 692,000.00 |
| Dec 31, 2022 | 696,000.00 |
| Sep 30, 2022 | 713,000.00 |
| Jun 30, 2022 | 713,000.00 |
| Mar 31, 2022 | 715,000.00 |
| Dec 31, 2021 | 715,000.00 |
| Sep 30, 2021 | 725,000.00 |
| Jun 30, 2021 | 725,000.00 |
| Mar 31, 2021 | 725,000.00 |
| Dec 31, 2020 | 732,000.00 |
| Sep 30, 2020 | 733,000.00 |
| Jun 30, 2020 | 737,000.00 |
| Mar 31, 2020 | 769,000.00 |
| Dec 31, 2019 | 778,000.00 |
| Sep 30, 2019 | 783,000.00 |
| Jun 30, 2019 | 1.22 Mn |
API Access
AIM ImmunoTech Preferred Shares API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=preferred-shares&ticker=AIM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "preferred-shares", "ticker": "AIM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=preferred-shares&ticker=AIM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();